Impact of hydroxyurea on clinical events in the BABY HUG trial

The Pediatric Hydroxyurea Phase 3 Clinical Trial (BABY HUG) was a phase 3 multicenter, randomized, double-blind, placebo-controlled clinical trial of hydroxyurea in infants (beginning at 9-18 months of age) with sickle cell anemia. An important secondary objective of this study was to compare clinic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Thornburg, Courtney D., Files, Beatrice A., Luo, Zhaoyu, Miller, Scott T., Kalpatthi, Ram, Iyer, Rathi, Seaman, Phillip, Lebensburger, Jeffrey, Alvarez, Ofelia, Thompson, Bruce, Ware, Russell E., Wang, Winfred C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2012
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3507142/
https://ncbi.nlm.nih.gov/pubmed/22915643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-03-419879
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados